Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Chronic Pain × Ketorolac × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain, Postoperative 3 Pain 3 Agnosia 3 Inflammation 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Thyroid Nodule 1 Reperfusion Injury 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Obesity 1 Neoplasms 1 Multiple Myeloma 1 Multiple Endocrine Neoplasia Type 1 1 Lymphoma, Follicular 1 Lymphoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Liver Diseases 1 Kidney Neoplasms 1 Ileus 1 Goiter 1 Fallopian Tube Neoplasms 1 End Stage Liver Disease 1 Emergencies 1 Diverticulosis, Colonic 1 Diverticulitis, Colonic 1 Curative Breast Cancer Surgery 1 Constipation 1

Interventions

Morphine 7 Surveys and Questionnaires 6 Ketamine 5 Fentanyl 4 Sodium Chloride 3 Saline Solution 3 Lidocaine 3 Educational Status 3 Dexmedetomidine 3 Cognitive Behavioral Therapy 3 Anesthetics, Local 3 Pregabalin 2 Mindfulness-Based Stress Reduction 2 Hypnosis 2 Control Groups 2 Bupivacaine 2 Acetaminophen 2 ziconotide 1 tianeptine 1 siltuximab 1 onabotulinum toxin A 1 nabiximols 1 morphine, naltrexone combination 1 erenumab 1 Yoga 1 Waiting Lists 1 Transcutaneous Electric Nerve Stimulation 1 Tramadol 1 Telemedicine 1 Tea 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01789216 2021-02-03

PAIN

Major Extremity Trauma Research Consortium

Phase 3 Completed

Lymphoma, Follicular, Chronic Pain, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡